Pure Bioscience's market cap is currently ―. The company's EPS TTM is $-0.032; its P/E ratio is -2.06; Pure Bioscience is scheduled to report earnings on June 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Oct 23	Apr 23	Jan 23	Oct 22	Jul 22
Income Statement	-
Total Revenue	$ 722.00K	$ 406.00K	$ 397.00K	$ 471.00K	$ 412.00K
Gross Profit	$ 442.00K	$ 196.00K	$ 197.00K	$ 257.00K	$ 112.00K
EBIT	$ -711.00K	$ 1.69M	$ -1.06M	$ -991.00K	$ -1.23M
EBITDA	$ -674.00K	$ 1.73M	$ -1.02M	$ -961.00K	$ -1.18M
Net Income Common Stockholders	$ -735.00K	$ 1.69M	$ -1.06M	$ -993.00K	$ -1.23M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.44M	$ 856.00K	$ 1.56M	$ 2.45M	$ 3.39M
Total Assets	$ 2.25M	$ 1.82M	$ 2.53M	$ 3.70M	$ 4.48M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -1.44M	$ -856.00K	$ -1.56M	$ -2.45M	$ -3.39M
Total Liabilities	$ 2.63M	$ 569.00K	$ 463.00K	$ 699.00K	$ 575.00K
Stockholders Equity	$ -383.00K	$ 1.25M	$ 2.07M	$ 3.00M	$ 3.91M
Cash Flow	-
Free Cash Flow	$ -440.00K	$ -704.00K	$ -967.00K	$ -939.00K	$ -620.00K
Operating Cash Flow	$ -440.00K	$ -665.00K	$ -967.00K	$ -902.00K	$ -603.00K
Investing Cash Flow	-	$ -39.00K	-	$ -37.00K	$ -17.00K
Financing Cash Flow	$ 785.00K	-	-	-	$ 3.50M

Currency in USD

Pure Bioscience Earnings and Revenue History

Income Statement >

Pure Bioscience Debt to Assets

Balance Sheet >

Pure Bioscience Cash Flow

Cash Flow >

Pure Bioscience Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing